Diagnostic Adoption is dependent on Diagnostic Test Funding at Launch

In part 6 of the series, ‘Personalized Medicine: What Pharma should do to get Ready', Tessa Sandberg of Diaceutics discusses why pharma should consider funding a diagnostic test at launch to ensure adoption.|In part 6 of the series, ‘Personalized Medicine: What Pharma should do to get Ready', Tessa Sandberg of Diaceutics discusses why pharma should consider funding a diagnostic test at launch to ensure adoption.|In part 6 of the series, ‘Personalized Medicine: What Pharma should do to get Ready', Tessa Sandberg of Diaceutics discusses why pharma should consider funding a diagnostic test at launch to ensure adoption.|In part 6 of the series, ‘Personalized Medicine: What Pharma should do to get Ready', Tessa Sandberg of Diaceutics discusses why pharma should consider funding a diagnostic test at launch to ensure adoption.